COVID-19 Archives | Oncotarget

Oncotarget News

Figure 4: The effect of SARS-CoV-2 spike on cell growth and death.

Transfected SARS-CoV-2 Spike DNA Suppresses Cancer Cell Response to Chemotherapy

May 6, 2024

Our findings have implications for the natural history of prolonged or repeated SARS-CoV-2 infection as well as design of anti-COVID-19 vaccines that are administered repeatedly as booster shots.”BUFFALO, NY-... read more

Figure 9: One-step SARS-COv2 genome assembly in yeast S. cerevisiae using transformation-associated recombination (TAR) in yeast

Oncotarget

Transformation-associated Recombination (TAR) Cloning and Its Applications

January 8, 2024

TAR cloning is used to genetically engineer synthetic viruses with novel properties that may be used for the development of new vaccines.”BUFFALO, NY- January 8, 2024 – A new review... read more

Oncotarget

Reassessing COVID-19 Precautions in 2023

September 27, 2023

The balance between appropriate precautions and the harm of social isolation always requires a thorough appraisal.”BUFFALO, NY- September 27, 2023 – A new editorial paper was published in Oncotarget's Volume... read more

Figure 1: Demographic factors, comorbidities and therapy regime of the melanoma patients in percentage, age in years.

Oncotarget

Oncotarget | Impact of Covid-19 on Management of Patients With Metastatic Melanoma

January 11, 2023

In this study, we aimed to analyze our experience with patients suffering from Sars-CoV-2 infection while receiving treatment for metastatic melanoma.” BUFFALO, NY- January 11, 2023 – A new research... read more

Oncotarget

Quote Card: Sergei Kurenov on Cancer Research

November 12, 2020

For the past three summers, Impact Journals has sponsored the Open Access team. The peloton was captained by Sergei Kurenov, who is the Director of Surgical Simulation at... read more

Oncotarget

Why We Ride: Liliya Novototskaya

October 13, 2020

My name is Liliya Novototskaya. Since 2007, I have been with Dr. Andrei Gudkov’s lab at Roswell Park Comprehensive Cancer Center, working as a Research Associate in the Cell... read more

Oncotarget

Captain of Team Open Access Interviewed About 2020 Ride for Roswell

October 1, 2020

This year marked the 25th anniversary of the Ride for Roswell, an annual fundraiser that welcomes thousands of cyclers to help raise donations for cancer research. The 2020 edition, dubbed... read more

Oncotarget

Cancer Won’t Stop For a Pandemic, and Neither Did the Ride for Roswell

October 1, 2020

Against unlikely odds, the Ride for Roswell’s 2020 Summer of the Ride in Buffalo, New York, was a remarkable success. In the midst of a global pandemic and the... read more

Oncotarget

Buffalo’s Ride for Roswell: A Cycling Event to Fight Cancer

October 1, 2020

There’s a ride to end cancer in the city of Buffalo, NY. It’s called the Ride for Roswell, and it’s an annual bicycle ride that raises... read more

Oncotarget

Open-Access Medical Journal Publishes Ground-Breaking COVID-19 Studies

May 26, 2020

The first official cases of COVID-19 are roughlyfive months behind us and the majority of milestones we’ve reached sincehaven’t been overly encouraging. Global infection totals, death... read more